105 related articles for article (PubMed ID: 33678115)
41. Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
Kubota H; Hirai T; Yamauchi A; Ogo A; Matsumoto H; Ueno T
Anticancer Res; 2020 Sep; 40(9):5043-5048. PubMed ID: 32878792
[TBL] [Abstract][Full Text] [Related]
42. Protective effects of eicosapentaenoic acid in adipocyte-breast cancer cell cross talk.
Al-Jawadi A; Rasha F; Ramalingam L; Alhaj S; Moussa H; Gollahon L; Dharmawardhane S; Moustaid-Moussa N
J Nutr Biochem; 2020 Jan; 75():108244. PubMed ID: 31704550
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic effects of 4'-hydroxychalcone on human neuroblastoma cells (SH-SY5Y).
de Moura Escobar SJ; Simone M; Martin N; de Oliveira Ribeiro CA; Martinez GR; Winnischofer SMB; Witting PK; Rocha MEM
Toxicol In Vitro; 2019 Dec; 61():104640. PubMed ID: 31493544
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis in human pancreatic cancer cells induced by eicosapentaenoic acid.
Shirota T; Haji S; Yamasaki M; Iwasaki T; Hidaka T; Takeyama Y; Shiozaki H; Ohyanagi H
Nutrition; 2005 Oct; 21(10):1010-7. PubMed ID: 16157238
[TBL] [Abstract][Full Text] [Related]
45. Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells.
Zhu DM; Uckun FM
Clin Cancer Res; 2000 Jun; 6(6):2456-63. PubMed ID: 10873099
[TBL] [Abstract][Full Text] [Related]
46. In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells.
Hampel U; Krüger M; Kunnen C; Garreis F; Willcox M; Paulsen F
Exp Eye Res; 2015 Nov; 140():139-148. PubMed ID: 26335632
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid.
Palakurthi SS; Flückiger R; Aktas H; Changolkar AK; Shahsafaei A; Harneit S; Kilic E; Halperin JA
Cancer Res; 2000 Jun; 60(11):2919-25. PubMed ID: 10850438
[TBL] [Abstract][Full Text] [Related]
48. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
Beck SA; Smith KL; Tisdale MJ
Cancer Res; 1991 Nov; 51(22):6089-93. PubMed ID: 1657378
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
50. Necrosis and apoptosis in lymphoma cell lines exposed to eicosapentaenoic acid and antioxidants.
Heimli H; Finstad HS; Drevon CA
Lipids; 2001 Jun; 36(6):613-21. PubMed ID: 11485166
[TBL] [Abstract][Full Text] [Related]
51. Eicosapentaenoic acid disrupts the balance between Tregs and IL-17+ T cells through PPARγ nuclear receptor activation and protects cardiac allografts.
Ye P; Li J; Wang S; Xie A; Sun W; Xia J
J Surg Res; 2012 Mar; 173(1):161-70. PubMed ID: 20950829
[TBL] [Abstract][Full Text] [Related]
52. The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line.
Ogo A; Miyake S; Kubota H; Higashida M; Matsumoto H; Teramoto F; Hirai T; Ueno T
Anticancer Res; 2021 Apr; 41(4):1771-1778. PubMed ID: 33813381
[TBL] [Abstract][Full Text] [Related]
53. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
J Natl Cancer Inst; 2004 Oct; 96(19):1457-66. PubMed ID: 15467035
[TBL] [Abstract][Full Text] [Related]
54. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro.
Lai PB; Ross JA; Fearon KC; Anderson JD; Carter DC
Br J Cancer; 1996 Nov; 74(9):1375-83. PubMed ID: 8912532
[TBL] [Abstract][Full Text] [Related]
55. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants.
Tsai WS; Nagawa H; Kaizaki S; Tsuruo T; Muto T
J Gastroenterol; 1998 Apr; 33(2):206-12. PubMed ID: 9605950
[TBL] [Abstract][Full Text] [Related]
57. Use of L-asparaginase in childhood ALL.
Müller HJ; Boos J
Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
[TBL] [Abstract][Full Text] [Related]
58. Eicosapentaenoic acid and docosahexaenoic acid reduce UVB- and TNF-alpha-induced IL-8 secretion in keratinocytes and UVB-induced IL-8 in fibroblasts.
Storey A; McArdle F; Friedmann PS; Jackson MJ; Rhodes LE
J Invest Dermatol; 2005 Jan; 124(1):248-55. PubMed ID: 15654981
[TBL] [Abstract][Full Text] [Related]
59. Low Sucrose, Omega-3 Enriched Diet Has Region-Specific Effects on Neuroinflammation and Synaptic Function Markers in a Mouse Model of Doxorubicin-Based Chemotherapy.
Orchard TS; Gaudier-Diaz MM; Phuwamongkolwiwat-Chu P; Andridge R; Lustberg MB; Bomser J; Cole RM; Belury MA; DeVries AC
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30567351
[TBL] [Abstract][Full Text] [Related]
60. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
Pappalardo G; Almeida A; Ravasco P
Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
